- Report
- June 2023
- 136 Pages
Global
From €2402EUR$2,499USD£2,060GBP
- Report
- May 2023
- 141 Pages
Global
From €2402EUR$2,499USD£2,060GBP
- Report
- January 2024
- 200 Pages
Global
From €2393EUR$2,490USD£2,052GBP
- Report
- January 2024
- 150 Pages
Global
From €4662EUR$4,850USD£3,997GBP
- Report
- March 2024
- 200 Pages
Global
From €1913EUR$1,990USD£1,640GBP
- Report
- July 2023
- 210 Pages
Global
From €1913EUR$1,990USD£1,640GBP
- Report
- January 2024
- 181 Pages
Global
From €4710EUR$4,900USD£4,039GBP
- Report
- October 2023
- 190 Pages
Global
From €4710EUR$4,900USD£4,039GBP
- Report
- February 2024
- 197 Pages
Global
From €4662EUR$4,850USD£3,997GBP
- Report
- November 2023
- 178 Pages
Global
From €4710EUR$4,900USD£4,039GBP
- Report
- October 2023
- 169 Pages
Global
From €2403EUR$2,500USD£2,061GBP
- Report
- February 2024
- 115 Pages
Global
From €4565EUR$4,750USD£3,915GBP
- Report
- February 2024
- 143 Pages
Global
From €4565EUR$4,750USD£3,915GBP
- Report
- June 2023
- 25 Pages
Global
From €4801EUR$4,995USD£4,117GBP
- Report
- January 2024
- 147 Pages
Global
From €4085EUR$4,250USD£3,503GBP
- Report
- January 2024
- 200 Pages
Global
From €3989EUR$4,150USD£3,421GBP
- Report
- January 2024
- 200 Pages
Global
From €3989EUR$4,150USD£3,421GBP
- Report
- October 2023
- 145 Pages
Global
From €3028EUR$3,150USD£2,596GBP
- Report
- October 2023
- 145 Pages
Global
From €3028EUR$3,150USD£2,596GBP
- Report
- January 2024
- 200 Pages
Global
From €3989EUR$4,150USD£3,421GBP
The Cardiac Valve market is a segment of the Cardiovascular Devices industry, which includes a range of products used to diagnose and treat heart conditions. Cardiac valves are used to regulate the flow of blood through the heart, and can be either mechanical or biological. Mechanical valves are typically made of metal and are designed to last for many years, while biological valves are made of animal tissue and are designed to be replaced over time. Both types of valves are used to treat a variety of heart conditions, including aortic stenosis, mitral regurgitation, and tricuspid regurgitation.
The Cardiac Valve market is highly competitive, with a number of companies offering a range of products. Major players in the market include Edwards Lifesciences, Medtronic, Boston Scientific, Abbott, and LivaNova. Other companies in the market include CryoLife, Symetis, and Neovasc. Show Less Read more